Skip to main content
Premium Trial:

Request an Annual Quote

Gene Duplications Enable Sea Snake to See More Color

The annulated sea snake has evolved to see more colors after an ancestor lost that ability, according to a new study appearing in Genome Biology and Evolution. In it, researchers from Australia, the UK, and Vietnam examined published reference genomes for five elapid snake species. Elapid snakes are a family of venomous snakes whose ancestors had lost vision-related opsin genes as they lived in low-light areas, but some of the snakes have more recently shifted to new, brighter environments. Within four taxa — the terrestrial tiger snake and banded krait (Notechis scutatus and Bungarus multicinctus), the amphibious sea krait (Laticauda laticaudata) and the fully marine sea snake — Hydrophis curtus — the researchers noted single copies of rhodopsin 1, long-wavelength opsin, and short-wavelength opsin 1 (SWS1), as expected. But within the annulated sea snake Hydrophis cyanocinctus, they uncovered four intact SWS1 genes, including two that were inverted. "We believe that recent gene duplications have dramatically expanded the range of colors sea snakes can see," first author Isaac Rossetto, a PhD student at the University of Adelaide, says in a statement.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.